(Q48894182)

16 February 2018

title

Parkinson's disease and related neurodegenerative synucleinopathies linked to progressive accumulations of synuclein aggregates in brain. (English)

1 reference

16 February 2018

1 reference

1 reference

1 reference

J Q. Trojanowski

1

1 reference

16 February 2018

V M.-Y. Lee

series ordinal

2

1 reference

16 February 2018

publication date

1 July 2001

1 reference

16 February 2018

number of pages

5

1 reference

Parkinsonism and Related Disorders

inferred from page(s)

published in

1 reference

16 February 2018

volume

7

1 reference

16 February 2018

issue

3

1 reference

16 February 2018

page(s)

247-251

1 reference

16 February 2018

Parkinson's disease. First of two parts

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900065-1

7 January 2021

Synucleins in synaptic plasticity and neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900065-1

7 January 2021

Filamentous nerve cell inclusions in neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900065-1

7 January 2021

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900065-1

7 January 2021

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900065-1

7 January 2021

Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900065-1

7 January 2021

Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900065-1

7 January 2021

Antibodies to alpha-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900065-1

7 January 2021

Alpha synuclein in neurodegenerative disorders: murderer or accomplice?

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900065-1

7 January 2021

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900065-1

7 January 2021

Alpha-synuclein in Lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900065-1

7 January 2021

NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900065-1

7 January 2021

A panel of epitope-specific antibodies detects protein domains distributed throughout human alpha-synuclein in Lewy bodies of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900065-1

7 January 2021

Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900065-1

7 January 2021

Synthetic filaments assembled from C-terminally truncated alpha-synuclein

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900065-1

7 January 2021

Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900065-1

7 January 2021

Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900065-1

7 January 2021

Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900065-1

7 January 2021

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900065-1

7 January 2021

Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900065-1

7 January 2021

Neocortical lewy body counts correlate with dementia in the Lewy body variant of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900065-1

7 January 2021

Widespread alterations of alpha-synuclein in multiple system atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900065-1

7 January 2021

Alpha-synuclein immunoreactivity is present in axonal swellings in neuroaxonal dystrophy and acute traumatic brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900065-1

7 January 2021

Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900065-1

7 January 2021

Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900065-1

7 January 2021

Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900065-1

7 January 2021

Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900065-1

7 January 2021

Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900065-1

7 January 2021

The expression of alpha-, beta-, and gamma-synucleins in olfactory mucosa from patients with and without neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900065-1

7 January 2021

Neurofilament functions in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900065-1

7 January 2021

Selective degeneration fo Purkinje cells with Lewy body-like inclusions in aged NFHLACZ transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900065-1

7 January 2021

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900065-1

7 January 2021

Alzheimer's disease and Parkinson's disease: distinct entities or extremes of a spectrum of neurodegeneration?

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900065-1

7 January 2021

α-synuclein—a link between Parkinson and Alzheimer diseases?

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900065-1

7 January 2021

Failure to replicate a protective effect of allele 2 of NACP/alpha-synuclein polymorphism in Alzheimer's disease: an association study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900065-1

7 January 2021

Increased susceptibility to sporadic Parkinson's disease by a certain combined alpha-synuclein/apolipoprotein E genotype

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900065-1

7 January 2021

Genetic studies in Alzheimer's disease with an NACP/alpha-synuclein polymorphism.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900065-1

7 January 2021

10.1016/S1353-8020(00)00065-1

Identifiers

DOI

1 reference

16 February 2018

1 reference

16 February 2018